The American College of Surgeons Health Policy Research Institute

American College of Surgeons Health Policy Research Institute
Advancing Health Policy Information
for Surgery in the United States

Reading a Verified FDA Alert About Compounded Drugs

Compounding risk alerts · reporting protocol

An FDA compounding risk alert is bounded by the preparation, concern, audience and recommendations in the exact agency notice. This guide provides a complete reporting framework and does not invent a future alert.

Evidence requirement: verify the exact alert before applying this framework to a current event.Framework source retrieved August 27, 2026

What the FDA source says

FDA states that it issues compounding risk alerts to inform healthcare professionals and compounders about risks associated with compounded drugs, including adverse events, outbreaks and drug-quality issues. The agency’s index is a collection of distinct notices, not a blanket warning about every compounded preparation.

The newsroom must therefore open one exact alert and keep its product description, route or formulation, affected audience, evidence and agency language together.

Source fields to capture

  1. FDA alert title, publication date and update date
  2. Exact compounded preparation and route, when stated
  3. Quality, dosing, contamination or other concern named by FDA
  4. Evidence described: reports, outbreak, inspection, testing or another source
  5. Affected audience and setting
  6. Agency recommendations and reporting pathway
Do not generalize beyond the notice

A concern about one preparation, route, source or labeling practice does not establish that every compounded product—or an FDA-approved product with a similar name—is affected.

Who is affected

The alert defines whether its audience includes compounders, healthcare professionals, patients or consumers. The article can help readers match identifiers and locate the complete notice. It cannot diagnose an adverse event, verify the source of an individual product or determine treatment.

Do not add instructions to stop, replace, dilute or otherwise modify a medicine. Any action language must be attributed to the exact FDA alert, and individual questions should be directed to a licensed clinician or pharmacist.

Prepublication checklist

  • The exact alert is current and opens on FDA.gov.
  • Every product identifier matches the notice.
  • No stronger causal language has been added.
  • Audience-specific instructions remain attributed.
  • A visible retrieval time and correction plan are present.

If an alert has implications for a procedural setting, the Surgical Workforce and Care Access hub provides the separate method for assessing actual facility capacity.

Primary source framework

U.S. Food and Drug Administration, Compounding Risk Alerts. Index retrieved August 27, 2026. Mandatory refresh: add the exact dated alert before publication.

Scroll to Top